PTC Therapeutics Inc.

NASDAQ: PTCT · Real-Time Price · USD
48.35
-0.35 (-0.72%)
At close: Aug 15, 2025, 2:56 PM

PTC Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-363.3M -626.6M -559.02M -523.9M
Depreciation & Amortization
75.66M 236.59M 128.84M 64.13M
Stock-Based Compensation
74.61M 131.21M 110.33M 103.51M
Other Working Capital
121.25M 5.72M -57.74M -4.01M
Other Non-Cash Items
58.7M 151.32M 82.81M 128.33M
Deferred Income Tax
-55.91M -46.93M -34.28M 377K
Change in Working Capital
102.54M -4M -85.33M -23.79M
Operating Cash Flow
-107.69M -158.42M -356.65M -251.33M
Capital Expenditures
-6.5M -120.62M -152.46M -85.33M
Cash Acquisitions
n/a n/a 128.44M 57.12M
Purchase of Investments
-669.93M -212.48M -75.55M -543.27M
Sales Maturities Of Investments
597.74M 156.37M 518.19M 847.78M
Other Investing Acitivies
122.88M -92.18M -128.44M -57.12M
Investing Cash Flow
44.18M -176.74M 290.18M 219.18M
Debt Repayment
-1.49M -301.38M 148.72M -2.22M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
223.59M 917.78M -30.77M n/a
Financial Cash Flow
255.87M 646.4M 167.95M 20.88M
Net Cash Flow
185.03M 314.36M 98.71M -19.09M
Free Cash Flow
-114.19M -279.04M -509.11M -336.66M